Cargando…

gMS-Classifier1 does not predict disability progression in multiple sclerosis

Detalles Bibliográficos
Autores principales:	van Rossum, Johannis A, Killestein, Joep, Villar, Luisa M, Riskind, Peter N, Freedman, Mark S, Teunissen, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545617/ https://www.ncbi.nlm.nih.gov/pubmed/30168749 http://dx.doi.org/10.1177/1352458518798048

Ejemplares similares

Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis
por: Arrambide, Georgina, et al.
Publicado: (2013)

Why gms?
por: Reinauer, Hans
Publicado: (2003)

Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)

Infusion-related events during natalizumab: No need for post-infusion monitoring
por: Loonstra, Floor C, et al.
Publicado: (2019)

GMS Hygiene and Infection Control
por: Kramer, Axel, et al.
Publicado: (2013)

Emerging safety issues in alemtuzumab-treated MS patients
por: Killestein, Joep, et al.
Publicado: (2019)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Thanking the reviewers of GMS German Medical Science
por: Reinauer, Hans
Publicado: (2011)

GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW
por: Gahr, Ralf H.
Publicado: (2012)

GMS Ophthalmology Cases – An Open Access Journal
por: Kirchhof, Bernd, et al.
Publicado: (2011)

Acknowledgement to the Reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2018)

Acknowledgement to the Reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2019)

Acknowledgement to the Reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2017)

Acknowledgement to the reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2020)

Acknowledgement to the reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2021)

Acknowledgement to the reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2022)

Acknowledgement to the reviewers of GMS Journal for Medical Education
por: Fischer, Martin R., et al.
Publicado: (2023)

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
por: Sestito, Claudia, et al.
Publicado: (2017)

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2017)

Idebenone does not inhibit disability progression in primary progressive MS
por: Kosa, Peter, et al.
Publicado: (2020)

Acknowledgment to the Reviewers of GMS Zeitschrift für Medizinische Ausbildung
por: Fischer, Martin R., et al.
Publicado: (2014)

Acknowledgment to the Reviewers of GMS Zeitschrift für Medizinische Ausbildung
por: Fischer, Martin R., et al.
Publicado: (2015)

Acknowledgement to the Reviewers of GMS Zeitschrift für Medizinische Ausbildung
por: Fischer, Martin R., et al.
Publicado: (2016)

Factors influencing the variation in GMS prescribing expenditure in Ireland
por: ConwayLenihan, A., et al.
Publicado: (2016)

Mental Health Disorder Therapeutic Modalities Modified for the GMS
por: Sumneangsanor, Tipsuda, et al.
Publicado: (2017)

Keep your eyes on the prize: Tackling breakthrough COVID-19 in MS patients
por: van Kempen, Zoé LE, et al.
Publicado: (2021)

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

The plasma peptides of Alzheimer’s disease
por: Florentinus-Mefailoski, Angelique, et al.
Publicado: (2021)

GMS German Medical Science: Best Paper Award 2013
por: Reinauer, Hans
Publicado: (2014)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Blood platelet RNA enables the detection of multiple sclerosis
por: Sol, Nik, et al.
Publicado: (2020)

Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis
por: Tommasin, Silvia, et al.
Publicado: (2021)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
por: Bruinsma, Ilona B., et al.
Publicado: (2017)

Recommendations for reviewing a manuscript for the GMS Zeitschrift für Medizinische Ausbildung
por: Schüttpelz-Brauns, Katrin, et al.
Publicado: (2010)

EuGMS 2019 Congress report: evidence-based medicine in geriatrics
por: Hope, Suzy V., et al.
Publicado: (2020)

Genotyping by multiplexed sequencing (GMS): A customizable platform for genomic selection
por: Ruff, Travis M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sopmo8mmlsgl4qijrj73f180tt